Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review

December 2021 | 45 pages | ID: S6722743350EN
GlobalData

Abstracts

Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from the attack of immune system. Its major pipeline products include human donor islets, microencapsulated islets; microencapsulated stem cell derived cells; corrected patient cells; allograft immune protected cells; and autograft thyroid cells. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes, thyroid problems, and blood disorders such as hemophilia A, and other diseases. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp Key Recent Developments

Dec 14,2021: Sernova appoints Christopher Barnes as Vice President, investor relations & grants options/DSUs
Dec 02,2021: Sernova announces appointment of executive chair to complement its management team
Sep 29,2021: Sernova engages New York-Based LifeSci Advisors as US investor relations partner
Jun 30,2021: Industry veteran Frank Shannon joins Sernova as VP Clinical Development and Regulatory Affairs
May 04,2021: Sernova announces the nomination of seasoned pharma executive Dr. Mohammad Azab to its board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Sernova Corp - Key Facts
Sernova Corp - Key Employees
Sernova Corp - Key Employee Biographies
Sernova Corp - Major Products and Services
Sernova Corp - History
Sernova Corp - Company Statement
Sernova Corp - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sernova Corp - Business Description
R&D Overview
Sernova Corp - Corporate Strategy
Sernova Corp - SWOT Analysis
SWOT Analysis - Overview
Sernova Corp - Strengths
Sernova Corp - Weaknesses
Sernova Corp - Opportunities
Sernova Corp - Threats
Sernova Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sernova Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sernova Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Sernova Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 14, 2021: Sernova appoints Christopher Barnes as Vice President, investor relations & grants options/DSUs
Dec 02, 2021: Sernova announces appointment of executive chair to complement its management team
Sep 29, 2021: Sernova engages New York-Based LifeSci Advisors as US investor relations partner
Jun 30, 2021: Industry veteran Frank Shannon joins Sernova as VP Clinical Development and Regulatory Affairs
May 04, 2021: Sernova announces the nomination of seasoned pharma executive Dr. Mohammad Azab to its board of directors
Jan 21, 2021: Sernova CEO to present regenerative medicine therapeutics platform update at the 2021 Cell & Gene Meeting on the Med
Jul 16, 2020: Dr. Anke M. Schulte joins Sernova Global Advisory Board
Apr 27, 2020: Sernova advances Annual General Meeting and CEO Teleconference to Friday May

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sernova Corp, Key Facts
Sernova Corp, Key Employees
Sernova Corp, Key Employee Biographies
Sernova Corp, Major Products and Services
Sernova Corp, History
Sernova Corp, Key Competitors
Sernova Corp, Ratios based on current share price
Sernova Corp, Annual Ratios
Sernova Corp, Annual Ratios (Cont...1)
Sernova Corp, Interim Ratios
Sernova Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sernova Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Sernova Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Sernova Corp, Performance Chart (2016 - 2020)
Sernova Corp, Ratio Charts
Sernova Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sernova Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021